NURHIDAYAH, M., F. FADILAH, A. ARSIANTI, and A. BAHTIAR. “IDENTIFICATION OF FGFR INHIBITOR AS ST2 RECEPTOR/INTERLEUKIN-1 RECEPTOR-LIKE 1 INHIBITOR IN CHRONIC OBSTRUCTIVE PULMONARY DISEASE DUE TO EXPOSURE TO E-CIGARETTES BY NETWORK PHARMACOLOGY AND MOLECULAR DOCKING PREDICTION”. International Journal of Applied Pharmaceutics, vol. 14, no. 2, Mar. 2022, pp. 256-6, doi:10.22159/ijap.2022v14i2.43784.